ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $1.6M invested in Entero Therapeutics in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$118K
2
+$66K
3
+$33.5K
4
BlackRock
BlackRock
New York
+$31K

Top Sellers

1
-$142K
2
-$141K
3
-$74K
4
Goldman Sachs
Goldman Sachs
New York
-$68K
5
WPW
Waldron Private Wealth
Pennsylvania
-$57K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$825K
2
$243K
3
$134K
4
$118K
5
$66K
6
$47K
7
$37K
8
$33K
9
$31K
10
$28K
11
$16K
12
$14K
13
$7K
14
$3K
15
$2K
16
$1K
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2